Work

Impact of polypharmacy on patients undergoing revascularisation for peripheral arterial disease

Year: 2024

Type: article

Study design: Observational Study

Source: VASA

DOI: 10.1024/0301-1526/a001164

Authors: Philipp Franke, Emmanuel Katsogridakis, Theodosios Bisdas, Athanasios Saratzis, Giovanni Torsello, Nikolaos Tsilimparis, Konstantinos Stavroulakis

Institutions: St. Franziskus Hospital, Liverpool University Hospitals NHS Foundation Trust, Athens Medical Center, University of Leicester, Ludwig-Maximilians-Universität München, Klinikum Rheine

Language: English

Topic: Peripheral Artery Disease Management

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institute for Health and Care Research, Academy of Medical Sciences

Awards: Cardiovascular Risk reduction In the NHS abdominal aortic aneurysm (AAA) Screening Programme: a co-developed cardiovascular prevention intervention (the CRISP study), A Community and Hospital cAre Bundle to improve the medical treatment of cLaudIcation and critical limb iSchaemia. The CHABLIS study., G5067476715, A randomised controlled trial assessing the clinical and cost-effectiveness of Endovascular vs. Open revascularisation in severe oCClusive aorto-iliac disease. The EVOCC trial., G8061519881

OpenAlex ID: W4404673123

FWCI: 2.657

Cites: 20

Cited by: 7

Related to: 10